Hematopoietic Stem
Cell Laboratory
In collaboration with the UPCI's IMCPL (Immunologic Monitoring Facility and Cellular Products Laboratory), the HSCLab is a member of PACT, which consists of three cGMP-level manufacturing facilities: UPCI, The Center for Cell and Gene Therapy (CAGT) at the Baylor College of Medicine, and the University of Minnesota's Molecular and Cellular Therapeutics facility (MMCT), and supported by the Administrative Center, The EMMES Corporation.
The PACT Group is an NHLBI-funded initiative that is committed to the advancement of effective cell therapies. PACT supports the development of novel somatic cell therapy products by providing production assistance to the cell therapy community, as well as educational training via web seminars and at meetings. Production assistance is provided through the funded contract manufacturing of therapeutic cell products at PACT processing facilities. These facilities offer scale-up capability and expertise in the translational development needed to produce cell therapy products under cGMP and cGTP regulations. PACT manufactures quality cell therapy products on behalf of investigators with funded clinical trials requiring support in product development and approval. PACT’s educational training focuses on three general areas: translational development/scale-up and manufacture of cell therapy products; and quality assurance and regulatory issues.
This project has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. NO1-HB-37165.